Nátrium-Hidrogénkarbonát B.Braun (Sodium Hydrogen Carbonate)

After oral administration, Sodium Hydrogen Carbonate dissociates into sodium and bicarbonate ions. The bicarbonate buffers hydrogen ions, forming carbonic acid, which is rapidly converted to carbon dioxide and water, thereby increasing systemic pH. This buffering capacity corrects acidemia and neutralizes gastric acid, while the sodium component contributes to extracellular fluid balance.

The prescribed dose of Sodium Hydrogen Carbonate is individualized by the treating clinician based on the specific indication, severity of the acid‑base disturbance, patient weight, renal function, and concurrent medications. Dosage adjustments are made according to laboratory monitoring of blood pH, electrolytes, and clinical response.

Sodium Hydrogen Carbonate should be used in pregnancy or lactation only when clearly needed and after a careful risk‑benefit assessment by a healthcare professional. Limited data suggest it can be used for acute correction of metabolic acidosis, but unnecessary exposure should be avoided, and monitoring of maternal and fetal electrolyte status is recommended.

To request Nátrium-Hidrogénkarbonát B.Braun, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide, and will ask for trade or institutional credentials. The sales team will then provide pricing, availability, shipping details (including any cold‑chain requirements), and assist with import documentation.

Sodium Hydrogen Carbonate provides rapid neutralization of gastric acid and systemic alkalinization, unlike calcium‑based antacids that primarily act locally. It delivers a higher sodium load, which can be advantageous for correcting metabolic acidosis but may be less suitable for patients requiring sodium restriction. Compared with magnesium or aluminum antacids, it has a lower risk of causing constipation or diarrhea.

Sodium Hydrogen Carbonate should be stored at ambient temperature, below 25 °C, in its original packaging. The container must be kept tightly closed to protect the powder from moisture and humidity, and it should be stored away from direct sunlight and sources of heat to maintain stability.

The product is supplied as a powder for oral use. It is typically reconstituted in water or another suitable liquid and ingested according to the dose prescribed by the clinician. Administration may be divided throughout the day, especially when used for chronic conditions, and should be taken with or without food as directed.

Serious risks include severe metabolic alkalosis, which can lead to respiratory depression, seizures, or cardiac arrhythmias, and hypernatremia, which may cause neurological symptoms such as confusion or coma. Rarely, anaphylactic reactions can occur, presenting with rash, swelling, and breathing difficulty, requiring immediate medical attention.

Patients with severe renal impairment, uncontrolled hypertension, or conditions requiring strict sodium restriction should avoid Sodium Hydrogen Carbonate unless specifically directed by a physician. Additionally, individuals with known hypersensitivity to sodium bicarbonate or related compounds should not use the product.